Ivan Horak

Ivan D.
Horak is the founder of Tikva Allocell Pte Ltd., established in 2023, where the title held is Chief Executive Officer.
Current jobs include Member at the American Society of Clinical Oncology, Inc., Member at the American Association for Cancer Research, Member at the American Society of Hematology, and Venture Advisor at Israel Biotech Fund.
Former jobs include Director-Oncology Clinical Research & Development at The Janssen Research Foundation from 1996 to 1999, CSO and EVP-Research & Development at Enzon Pharmaceuticals, Inc. from 2009 to 2010, Chief Scientific Officer and Executive VP at Immunomedics, Inc. from 2002 to 2005, Member at the Union for International Cancer Control, Vice President-Clinical Oncology at Pharmacia Corp.
from 1999 to 2002, Principal at the American College of Physicians, Inc., and Chief Medical & Scientific Officer at Tessa Therapeutics Ltd. Education includes a doctorate from the University of Commenius.